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statistically significant (see figure). Three STs were observed, all in the stable/unstable
angina group. Procedural success was 96% in all groups.
Conclusions: Clinical outcomes were not different among patients treated with the
Tryton stent presenting with stable/unstable angina, NSTEMI and STEMI. The use of the
Tryton stent seems to be safe and feasible in patients presenting with MI, including
STEMI.
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Background: Previous studies have suggested safety and efficacy of DES in patients
with AMI compared to bare metal stents. However, the very long-term follow-up of
patients with AMI treated with DES in the real-world clinical practice remains unknown.
Our objective was to investigate the late outcomes of patients with recent acute
myocardial infarction (MI) treated with drug-eluting stents (DES) in daily clinical
practice.
Methods: The DESIRE (Drug-Eluting Stent in the Real World) Registry is a prospective,
non-randomized clinical trial evaluating the long-term clinical FU of pts undergoing
elective or urgent percutaneous coronary intervention (PCI) with DES as the default
strategy in a single center. From 05/02 to 05/12, 4,229 pts (6,518 lesions) were treated
with 7,000 DES. Clinical FU was performed at 1, 6 and 12 months, and annually up to
10 years (FU in 97%, median 4.9 years). Patients were divided into 2 groups according
to their clinical presentation: Group 1 - patients with recent MI (30 days), n656;
Group 2 - patients without recent MI, n3,573, and results were compared.
Results: Group 1 had less co-morbidities, but more multivessel disease (71 vs. 62%,
p0.0002), thrombus containing lesions (12 vs. 1.4%, p0.001), TIMI flow 0/1 (8 vs.
1.2%, p0.001), and moderate/severe left ventricular dysfunction (20 vs. 8%, p0.001)
compared to Group 2. Overall, there were 1.60.8 stents/patient; Group 1 received more
glycoprotein IIb/IIIa inhibitors (13 vs. 2%, p0.001), but angiographic success was
similar in both groups (99%). Clinical outcomes are shown in the Table
Cumulative Events Group 1 Group 2 p value
Cardiac death 6.7% 3.6% 0.0003
MI 6.5% 7.1% 0.63
TLR 3% 5.1% 0.04
Stent thrombosis (ARC) 4.5% 2.0% 0.0001
- Early (30 days) 1.1% 0.2% 0.0004
- Late (1-12 months) 1.4% 0.5% 0.007
- Very late (12 months) 2.0% 1.3% 0.15
Conclusions: Patients with primary clinical presentation of recent MI (30 days)
undergoing DES had worse long-term prognosis compared to those without recent MI,
including increased rates of cardiac death (p0.0003) and stent thrombosis (P0.0001)
up to 10 years FU.
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Background: The clinical outcome of patients presenting coronary artery ectasia and
acute myocardial infarction is poorly defined. The aim of this study was to analyze the
mid-long term clinical outcome of patients treated by primary angioplasty in whom the
culprit lesion was localized in an ectatic vessel.
Methods: A systematic review of the databases of eight Italian centers identified 101
patients with coronary artery ectasia who were treated by primary percutaneous coronary
intervention (PCI). The end points of the study were the incidence of cardiac death, need
of any new revascularization, recurrence of acute myocardial infarction and the combined
end point of cardiac death and/or recurrence of acute myocardial infarction during a
follow-up mean time of 15.4 months. Cumulative cardiac mortality was evaluated with
Kaplan-Meier method. Cox proportional hazard model was used to calculate hazard ratios
(HR) and 95% confidence intervals (95% CI) for selected potential predictors of cardiac
mortality.
Results: The right coronary artery was the principal ectatic vessel involved in acute
myocardial infarction (54%), particularly in Type 3 ectasia (p0.001). Cardiac mortality
rate was 5.9% (95% CI: 1.3-10.5) in hospital, 7.1% (95% CI: 3.4-14.3) at 1 year, and
12.8% (95% CI: 6.2-25.7) at 2 years. The most important factors related with cardiac
death and survival were: male gender, TIMI 3, single lesion PCI and successful PCI
(reduced mortality), age  63.5 years, Killip class  1, and complicated PCI (increased
mortality).
Cox proportional-hazards model of cardiac death
Variables No. Deaths HR 95% CI p-value
Gender
Male 8 0.17 0.03–0.87 0.03
Mean age (years)
 63.5 8 4.54 0.96–21.40 0.056
Killip classification
Killip class  1 6 6.51 1.80–23.56 0.004
PCI characteristics
Single lesion PCI 6 0.25 0.07–0.96 0.04
TIMI
 3 4 0.27 0.08–0.98 0.047
PCI results
Successful 5 0.19 0.05–0.67 0.01
With
complications
3 4.75 1.18–19.10 0.03
Conclusions: Based on our observations, the clinical outcome at mid-long term of
patients with coronary artery ectasia treated by primary angioplasty in the setting of acute
myocardial infarction seems to be in line with that reported in the Italian epidemiological
registries for acute coronary syndromes. No association between different types of ectasia
and major adverse cardiac events was found.
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Background: It is not still unclear which procedure is superior between TRI and TFI in
terms of in-hospital morbidities and outcomes in acute myocardial infarction patients.
Methods: Using KORMI (Korean registry of myocardial infarction) data (from 2008
January to 2011 Aug), in-hospital morbidities and cumulative clinical outcomes of TRI
group were compared to those of TFI group in STEMI and NSTEMI patients. Data of
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